4.8 Article

Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Interleukin 13 and its role in gut defence and inflammation

Peter Mannon et al.

Article Pharmacology & Pharmacy

Interleukin-13 neutralization by two distinct receptor blocking mechanisms reduces immunoglobulin E responses and lung inflammation in cynomolgus monkeys

Marion T. Kasaian et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Article Allergy

IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys

Andrea Bree et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)

Article Biochemistry & Molecular Biology

Efficacy of IL-13 neutralization in a sheep model of experimental asthma

Marion T. Kasaian et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)

Review Allergy

IL-13 receptors and signaling pathways: An evolving web

GKK Hershey

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)

Article Allergy

Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma

K Arima et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)